Clinical Trials
Sponsor:
Sponsor Study ID:
Study Title:
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average Risk WNT Driven Medulloblastoma Patients
NCT Number:
NCT02724579
Phase:
II
Protocol Type:
Treatment
Age Group:
Both
Disease Sites:
Brain and Nervous System
Study Objectives:
This phase II trial studies how well reduced doses of radiation therapy to the brain and spine (craniospinal) and chemotherapy work in treating patients with newly diagnosed type of brain tumor called WNT)/Wingless (WNT)-driven medulloblastoma.
Study Documents
(MUSC NetID required for document access)